• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过相分离法制备的聚乳酸-羟基乙酸共聚物(PLGA)微粒中的聚合物侵蚀。

Polymer erosion in PLGA microparticles produced by phase separation method.

作者信息

Husmann M, Schenderlein S, Lück M, Lindner H, Kleinebudde P

机构信息

Ferring GmbH, Wittland 11, Kiel, Germany.

出版信息

Int J Pharm. 2002 Aug 21;242(1-2):277-80. doi: 10.1016/s0378-5173(02)00187-4.

DOI:10.1016/s0378-5173(02)00187-4
PMID:12176263
Abstract

This article deals with polymer erosion in biodegradable microparticles produced using the phase separation method. Poly(lactic-co-glycolic acid) copolymers with different compositions and molecular weights were employed. The microparticles were stored in phosphate buffer for 6 months. The molecular weight of the polymers was determined by size exclusion chromatography, and the weight loss was monitored gravimetrically. No weight loss was measured in the first weeks, although the molecular weight decreased significantly already from the start. After a certain storage period which was found to be specific for the type of polymer, the weight of the microparticles decreased rapidly. The start of this weight loss occurred when the molecular weight of the polymer in the degrading microparticles reached a threshold of approximately 15,000. This critical molecular weight was found to be identical for all investigated polymers, i.e. it was independent of the initial molecular weight of the polymer and of the lactic-glycolic ratio.

摘要

本文探讨了采用相分离法制备的可生物降解微粒中的聚合物侵蚀现象。使用了不同组成和分子量的聚(乳酸 - 乙醇酸)共聚物。将微粒在磷酸盐缓冲液中储存6个月。通过尺寸排阻色谱法测定聚合物的分子量,并采用重量法监测重量损失。在最初几周未检测到重量损失,尽管分子量从一开始就显著下降。经过特定的储存期(发现该储存期因聚合物类型而异)后,微粒的重量迅速下降。当降解微粒中聚合物的分子量达到约15,000的阈值时,开始出现这种重量损失。发现所有研究的聚合物的这个临界分子量是相同的,即它与聚合物的初始分子量以及乳酸 - 乙醇酸比例无关。

相似文献

1
Polymer erosion in PLGA microparticles produced by phase separation method.通过相分离法制备的聚乳酸-羟基乙酸共聚物(PLGA)微粒中的聚合物侵蚀。
Int J Pharm. 2002 Aug 21;242(1-2):277-80. doi: 10.1016/s0378-5173(02)00187-4.
2
Influence of average molecular weights of poly(DL-lactic acid-co-glycolic acid) copolymers 50/50 on phase separation and in vitro drug release from microspheres.聚(DL-乳酸-共-乙醇酸)50/50共聚物平均分子量对微球相分离及体外药物释放的影响
Pharm Res. 1990 Sep;7(9):928-34. doi: 10.1023/a:1015945806917.
3
Preparation and characterization of biodegradable urea-loaded microparticles as an approach for transdermal delivery.可生物降解的载尿素微粒的制备与表征:一种透皮给药途径
J Microencapsul. 2006 Sep;23(6):698-712. doi: 10.1080/02652040600789328.
4
The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers.由聚乳酸-乙醇酸共聚物(PLGA)与低分子量二嵌段共聚物的共混物制备的载紫杉醇微球的表征
Int J Pharm. 2007 Sep 5;342(1-2):6-17. doi: 10.1016/j.ijpharm.2007.04.022. Epub 2007 May 3.
5
Modification of biodegradable poly(malate) and poly(lactic-co-glycolic acid) microparticles with low molecular polyethylene glycol.用低分子聚乙二醇对可生物降解的聚(苹果酸)和聚(乳酸-乙醇酸共聚物)微粒进行改性。
Drug Dev Ind Pharm. 2009 Apr;35(4):449-54. doi: 10.1080/03639040802438357.
6
PLGA-PEG microspheres of teverelix: influence of polymer type on microsphere characteristics and on teverelix in vitro release.替瑞利克斯的聚乳酸-羟基乙酸共聚物-聚乙二醇微球:聚合物类型对微球特性及替瑞利克斯体外释放的影响
Int J Pharm. 2003 Aug 11;261(1-2):69-80. doi: 10.1016/s0378-5173(03)00272-2.
7
Biodegradable microspheres as controlled-release tetanus toxoid delivery systems.可生物降解微球作为破伤风类毒素控释给药系统
Vaccine. 1994 Mar;12(4):299-306. doi: 10.1016/0264-410x(94)90092-2.
8
Formulation of poly(D,L-lactic-co-glycolic acid) microparticles for rapid plasmid DNA delivery.用于快速递送质粒DNA的聚(D,L-乳酸-共-乙醇酸)微粒的制剂
J Control Release. 2000 May 15;66(2-3):229-41. doi: 10.1016/s0168-3659(99)00275-8.
9
Physicomechanical properties of biodegradable poly(D,L-lactide) and poly(D,L-lactide-co-glycolide) films in the dry and wet states.生物可降解聚(D,L-丙交酯)和聚(D,L-丙交酯-共-乙交酯)薄膜在干燥和湿润状态下的物理机械性能
J Pharm Sci. 2000 Dec;89(12):1558-66. doi: 10.1002/1520-6017(200012)89:12<1558::aid-jps6>3.0.co;2-8.
10
Gamma irradiation effects on molecular weight and in vitro degradation of poly(D,L-lactide-CO-glycolide) microparticles.γ射线辐照对聚(D,L-丙交酯-乙交酯)微粒分子量及体外降解的影响
Pharm Res. 1995 Jun;12(6):851-6. doi: 10.1023/a:1016256903322.

引用本文的文献

1
Application of PLGA in Tumor Immunotherapy.聚乳酸-羟基乙酸共聚物在肿瘤免疫治疗中的应用。
Polymers (Basel). 2024 Apr 30;16(9):1253. doi: 10.3390/polym16091253.
2
Biomolecular Liquid-Liquid Phase Separation for Biotechnology.用于生物技术的生物分子液-液相分离
BioTech (Basel). 2023 Apr 1;12(2):26. doi: 10.3390/biotech12020026.
3
Connecting primitive phase separation to biotechnology, synthetic biology, and engineering.将原始相分离与生物技术、合成生物学和工程联系起来。
J Biosci. 2021;46(3). doi: 10.1007/s12038-021-00204-z.
4
Long-term sustained release Poly(lactic-co-glycolic acid) microspheres of asenapine maleate with improved bioavailability for chronic neuropsychiatric diseases.马来酸阿塞那平聚乳酸-羟基乙酸共聚物长效微球的研制及其用于慢性神经精神疾病的生物利用度改善
Drug Deliv. 2020 Dec;27(1):1283-1291. doi: 10.1080/10717544.2020.1815896.
5
Artificial small-diameter blood vessels: materials, fabrication, surface modification, mechanical properties, and bioactive functionalities.人工小直径血管:材料、制造、表面改性、力学性能和生物活性功能。
J Mater Chem B. 2020 Mar 4;8(9):1801-1822. doi: 10.1039/c9tb01849b.
6
A potential in situ gel formulation loaded with novel fabricated poly(lactide-co-glycolide) nanoparticles for enhancing and sustaining the ophthalmic delivery of ketoconazole.一种载有新型制备的聚(丙交酯-共-乙交酯)纳米颗粒的潜在原位凝胶制剂,用于增强和维持酮康唑的眼部给药。
Int J Nanomedicine. 2017 Mar 8;12:1863-1875. doi: 10.2147/IJN.S131850. eCollection 2017.
7
Synchrotron-Based in Situ Characterization of the Scaffold Mass Loss from Erosion Degradation.基于同步加速器的原位表征支架因侵蚀降解导致的质量损失
J Funct Biomater. 2016 Jul 5;7(3):17. doi: 10.3390/jfb7030017.
8
A Uniform Ultra-Small Microsphere/SAIB Hybrid Depot with Low Burst Release for Long-Term Continuous Drug Release.一种具有低突释特性的均匀超小微球/SAIB混合长效制剂用于长期持续药物释放。
Pharm Res. 2015 Nov;32(11):3708-21. doi: 10.1007/s11095-015-1731-1. Epub 2015 Jun 16.
9
Injectable controlled release depots for large molecules.用于大分子的可注射控释制剂
J Control Release. 2014 Sep 28;190:240-53. doi: 10.1016/j.jconrel.2014.05.057. Epub 2014 Jun 12.
10
Biodegradable injectable in situ implants and microparticles for sustained release of montelukast: in vitro release, pharmacokinetics, and stability.用于孟鲁司特持续释放的可生物降解原位注射植入物和微粒:体外释放、药代动力学及稳定性
AAPS PharmSciTech. 2014 Jun;15(3):772-80. doi: 10.1208/s12249-014-0101-3. Epub 2014 Mar 20.